Related references
Note: Only part of the references are listed.Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation
Suryasarathi Dasgupta et al.
HAEMATOLOGICA (2007)
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Marilyn J. Manco-Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy
Jagadeesh Bayry et al.
DRUG DISCOVERY TODAY (2007)
Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A
S. C. Gouw et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+T lymphocytes
Suryasarathi Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
Jagadeesh Bayry et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells
Jagadeesh Bayry et al.
JOURNAL OF IMMUNOLOGY (2007)
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation
Peter W. Collins et al.
BLOOD (2007)
Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A
J. Astermark et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors
Suryasarathi Dasgupta et al.
BLOOD (2007)
Depletion of CD4(+)/CD25(high) regulatory T cells may enhance or uncover factor VIII-specific T-cell responses in healthy individuals
C. Kamate et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A
Jan Astermark et al.
BLOOD (2006)
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIIIC2 domain
F. E. Rawle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease
Shimon Sakaguchi et al.
IMMUNOLOGICAL REVIEWS (2006)
FVIII production by human lung microvascular endothelial cells
Marc Jacquemin et al.
BLOOD (2006)
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII
Sebastien Lacroix-Desmazes et al.
JOURNAL OF IMMUNOLOGY (2006)
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
Qizhen Shi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A unified theory of central tolerance in the thymus
YJ Liu
TRENDS IN IMMUNOLOGY (2006)
Regulated release of VWF and FVIII and the biologic implications
SL Haberichter et al.
PEDIATRIC BLOOD & CANCER (2006)
Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A
J Astermark et al.
BLOOD (2006)
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A
J Goudemand et al.
BLOOD (2006)
High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors
C Hausl et al.
BLOOD (2005)
Cutting edge:: Direct suppression of B cells by CD4+CD25+ regulatory T cells
HW Lim et al.
JOURNAL OF IMMUNOLOGY (2005)
LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo
N Bovenschen et al.
BLOOD (2005)
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins
TC Lei et al.
BLOOD (2005)
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor
N Bovenschen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Identification and removal of a promiscuous CD4+T cell epitope from the C1 domain of factor VIII
TD Jones et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Acquired hemophilia A: A concise review
M Franchini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Cutting edge:: Human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells
N Misra et al.
JOURNAL OF IMMUNOLOGY (2004)
In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody
JGG Gilles et al.
BLOOD (2004)
Inhibitors in hemophilia A: Mechanisms of inhibition, management and perspectives
NM Ananyeva et al.
BLOOD COAGULATION & FIBRINOLYSIS (2004)
Epitope repertoire of human CD4+ T cells on the A3 domain of coagulation factor VIII
MT Reding et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders
C Hausl et al.
BLOOD (2004)
T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects
GL Hu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Recognition of coagulation factor VIII by CD4+ T cells of healthy humans
GL Hu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
A Gringeri et al.
BLOOD (2003)
Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII
MT Reding et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency
N Bovenschen et al.
BLOOD (2003)
Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors
J Delgado et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Will the idiotypic network help to solve natural tolerance?
A Coutinho
TRENDS IN IMMUNOLOGY (2003)
Two classes of germline genes both derived from theVH1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII
EN van den Brink et al.
BLOOD (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
S Lacroix-Desmazes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A
G Rossi et al.
BLOOD (2001)
Molecular modifications in factor VIII concentrates produced from different plasma pools
E Saenko et al.
THROMBOSIS RESEARCH (2001)
Multiple VH genes are used to assemble human antibodies directed toward the A3-Cl domains of factor VIII
EN van den Brink et al.
BLOOD (2001)
Share Paper
